UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Isolation and partial characterisation of a protein from buck seminal plasma (Capra hircus), homologous to spermadhesins

Protein and peptide letters, 2002-08, Vol.9 (4), p.331-335

2002

Volltextzugriff (PDF)

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

The lancet. Diabetes & endocrinology, 2014-11, Vol.2 (11), p.875-884

2014

Volltextzugriff (PDF)

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

The New England journal of medicine, 2012-03, Vol.366 (10), p.914-924

2012

Volltextzugriff (PDF)

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

European journal of endocrinology, 2015-09, Vol.173 (3), p.313-323

2015

Volltextzugriff (PDF)

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

The journal of clinical endocrinology and metabolism, 2020-06, Vol.105 (6), p.e2247-e2260

2020

Volltextzugriff (PDF)

Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

The lancet. Diabetes & endocrinology, 2018-01, Vol.6 (1), p.17-26

2018

Volltextzugriff (PDF)

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis

Schizophrenia bulletin, 2022-01, Vol.48 (1), p.100-110

2022

Volltextzugriff (PDF)

Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective

Schizophrenia bulletin, 2021-07, Vol.47 (4), p.1018-1028

2021

Volltextzugriff (PDF)

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

Clinical endocrinology (Oxford), 2014-09, Vol.81 (3), p.408-417

2014

Volltextzugriff (PDF)

High variability in baseline urinary free cortisol values in patients with Cushing's disease

Clinical endocrinology (Oxford), 2014-02, Vol.80 (2), p.261-269

2014

Volltextzugriff (PDF)

Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families

Human mutation, 2010-08, Vol.31 (8), p.950-960

2010

Volltextzugriff (PDF)

Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil

The American journal of tropical medicine and hygiene, 2009-08, Vol.81 (2), p.240-247

2009

Volltextzugriff (PDF)

Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension trial

Pituitary, 2015-10, Vol.18 (5), p.604-612

2015

Volltextzugriff (PDF)

The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia

British journal of haematology, 2013-04, Vol.161 (2), p.224-236

2013

Volltextzugriff (PDF)

Computed Tomography Angiography for Detection of Middle Meningeal Artery Lesions Associated with Acute Epidural Hematomas

BioMed research international, 2014-01, Vol.2014 (2014), p.1-5

2014

Volltextzugriff (PDF)

Early-age Acute Leukemia: Revisiting Two Decades of the Brazilian Collaborative Study Group

Archives of medical research, 2016-11, Vol.47 (8), p.593-606

2016

Volltextzugriff (PDF)

Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil

International journal of epidemiology, 2008-08, Vol.37 (4), p.852-861

2008

Volltextzugriff (PDF)

Challenges in the use of NG2 antigen as a marker to predict MLL rearrangements in multi-center studies

Leukemia research, 2011-08, Vol.35 (8), p.1001-1007

2011

Volltextzugriff (PDF)

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

The journal of clinical endocrinology and metabolism, 2014-03, Vol.99 (3), p.791-799

2014

Volltextzugriff (PDF)

The genetic background of acromegaly

Pituitary, 2017-02, Vol.20 (1), p.10-21

2017

Volltextzugriff (PDF)

Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study

European journal of endocrinology, 2020-06, Vol.182 (6), p.583

2020

Volltextzugriff (PDF)

Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas

PloS one, 2015-02, Vol.10 (2), p.e0117107-e0117107

2015

Volltextzugriff (PDF)

Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly

Endocrine, 2016-07, Vol.53 (1), p.210-219

2016

Volltextzugriff (PDF)

Borneol reduces sympathetic vasomotor hyperactivity and restores depressed baroreflex sensitivity in rats with renovascular hypertension

Hypertension research, 2022-05, Vol.45 (5), p.802-813

2022

Volltextzugriff (PDF)

1 – 25 von 489

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(462)
Mit Volltextzugriff
(423)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Isolation and partial characterisation of a protein from buck seminal plasma (Capra hircus), homologous to spermadhesins

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis

Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

High variability in baseline urinary free cortisol values in patients with Cushing's disease

Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families

Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil

Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension trial

The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia

Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia

Computed Tomography Angiography for Detection of Middle Meningeal Artery Lesions Associated with Acute Epidural Hematomas

Early-age Acute Leukemia: Revisiting Two Decades of the Brazilian Collaborative Study Group

Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil

Challenges in the use of NG2 antigen as a marker to predict MLL rearrangements in multi-center studies

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

The genetic background of acromegaly

Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study

Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas

Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly

Borneol reduces sympathetic vasomotor hyperactivity and restores depressed baroreflex sensitivity in rats with renovascular hypertension

Aktive Filter

Suchergebnisse filtern